下调miR-4443/TIMP2信号通路增强HepG2细胞对索拉非尼的敏感性

您当前的位置：

首页 >

文章列表页 >

下调miR-4443/TIMP2信号通路增强HepG2细胞对索拉非尼的敏感性

基础医学 | 更新时间：2026-01-09

- 下调miR-4443/TIMP2信号通路增强HepG2细胞对索拉非尼的敏感性
- Down-regulation of miR-4443/TIMP2 signaling pathway enhances sorafenib sensitivity in HepG2 cells
- 第三军医大学学报 2021年43卷第3期页码：188-194
- 作者机构：
  
  400038 重庆，陆军军医大学(第三军医大学)基础医学院生物化学与分子生物学教研室
- 作者简介：
  
  [ 连继勤，E-mail：lianjiqin@sina.com LIAN Jiqin, E-mail:lianjiqin@sina.com
- 基金信息：
  
  国家自然科学基金面上项目(81572375);重庆市自然科学基金面上项目(CSTC2018jcyjA2018)
- DOI：10.16016/j.1000-5404.202008219
  中图分类号： R394.6;R735.7;R979.1
- 收稿：2020-08-26，
  
  修回：2020-10-29，
  
  纸质出版：2021-02-15
- 稿件说明：
移动端阅览
肖翰希, 张越婷, 孙梁博, 等. 下调miR-4443/TIMP2信号通路增强HepG2细胞对索拉非尼的敏感性[J]. 第三军医大学学报, 2021,43(3):188-194.

Hanxi XIAO, Yueting ZHANG, Liangbo SUN, et al. Down-regulation of miR-4443/TIMP2 signaling pathway enhances sorafenib sensitivity in HepG2 cells[J]. Journal of Third Military Medical University, 2021, 43(3): 188-194.
肖翰希, 张越婷, 孙梁博, 等. 下调miR-4443/TIMP2信号通路增强HepG2细胞对索拉非尼的敏感性[J]. 第三军医大学学报, 2021,43(3):188-194. DOI： 10.16016/j.1000-5404.202008219.

Hanxi XIAO, Yueting ZHANG, Liangbo SUN, et al. Down-regulation of miR-4443/TIMP2 signaling pathway enhances sorafenib sensitivity in HepG2 cells[J]. Journal of Third Military Medical University, 2021, 43(3): 188-194. DOI： 10.16016/j.1000-5404.202008219.

摘要

目的

2

探讨下调miR-4443/TIMP2信号通路后肝癌HepG2细胞对索拉非尼敏感性的影响。

方法

2

将HepG2细胞分为对照组(DMSO)与索拉非尼处理组(10 μmol/L)，索拉非尼处理HepG2细胞24 h后，RT-qPCR检测miR-4443的变化；脂质体法将miR-4443模拟物与miR-4443抑制剂转染HepG2细胞，通过CCK-8检测转染miR-4443模拟物或抑制剂后联用索拉非尼对HepG2细胞活性的影响；生物信息学预测miR-4443的下游靶基因，索拉非尼处理24 h后通过RT-qPCR和Western blot分别检测下游靶基因TIMP2 mRNA及其蛋白水平的变化；转染miR-4443模拟物、抑制剂后，RT-qPCR和Western blot分别检测TIMP2 mRNA以及蛋白含量的变化；在HepG2细胞中通过脂质体法转染TIMP2 siRNA，Western blot检测TIMP2蛋白含量；CCK-8检测敲低TIMP2后联用索拉非尼对HepG2细胞活性的影响。

结果

2

与对照组相比，索拉非尼处理组HepG2细胞中miR-4443的含量显著降低(

P

<

0.05)；转染miR-4443模拟物可显著降低索拉非尼对细胞活性的抑制(

P

<

0.05)，而转染其抑制剂则可显著增强索拉非尼的这一作用(

P

<

0.05)；生物信息学预测结果显示miR-4443结合的下游靶基因为TIMP2；索拉非尼处理后HepG2细胞中TIMP2的mRNA及蛋白水平显著升高(

P

<

0.05)；而在HepG2细胞中转染miR-4443的模拟物或抑制剂则可使TIMP2的mRNA表达量相应下降或上升，转染模拟物后TIMP2蛋白表达显著降低(

P

<

0.05)，表明miR-4443与TIMP2间存在调控关系；用TIMP2 siRNA降低TIMP2表达后，可显著增强索拉非尼对HepG2细胞活性的抑制效果(

P

<

0.05)。

结论

2

下调miR-4443/TIMP2信号通路可以增强HepG2细胞对索拉非尼的敏感性。

Abstract

Objective

2

To investigate the significance of down-regulating the miR-4443/TIMP2 pathway on sorafenib sensitivity in HepG2 cells.

Methods

2

HepG2 cells were divided into control group (DMSO) and sorafenib treatment group (10 μmol/L). After treatment for 24 h

the mRNA level of miR-4443 was measured by RT-qPCR. CCK-8 assay was used to study the effects of transfection with miR-4443 mimics or pretreatment of its inhibitor on the cell viability of HepG2 cells treated with sorafenib for 24 h. Bioinformatics analysis was used to predict the downstream target gene of miR-4443. The expression of TIMP2 at mRNA and protein levels was assessed by RT-qPCR and Western blotting in the HepG2 cells treated with sorafenib for 24 h

transfected with miR-4443 mimics or pretreatment of its inhibitor followed by sorafenib treatment. Then TIMP2 siRNA was transfected into HepG2 cells by liposome transfection

the content of TIMP2 protein was detected by Western blotting

and the effect of TIMP2 knockdown combined with sorafenib treatment on the viability of HepG2 cells was measured with CCK-8 assay.

Results

2

Sorafenib treatment decreased the expression of miR-4443 in HepG2 cells (

P

<

0.05). Overexpression of miR-4443 (transfection of miR-4443 mimics) significantly decreased the inhibitory effect of sorafenib on cell viability (

P

<

0.05)

while pretreatment of miR-4443 inhibitor could enhance the effect of the drug (

P

<

0.05). Bioinformatics analysis indicated that the downstream target gene of miR-4443 was TIMP2. The mRNA and protein levels of TIMP2 were obviously increased in HepG2 cells after sorafenib treatment (

P

<

0.05)

but the transfection of miR-4443 mimics or pretreatment of its inhibitor would down- or up-regulate the mRNA level of TIMP2

and the transfection of miR-4443 mimics decreased the protein level of TIMP2

indicating the regulative relationship between the 2 molecules. The transfection of TIMP2 siRNA decreased the expression of TIMP2 and then enhanced the inhibitory effect of sorafenib on HepG2 viability (

P

<

0.05).

Conclusion

2

Down-regulation of the miR-4443/TIMP2 pathway enhances sorafenib sensitivity in HepG2 cells.

关键词

Keywords

references

ZHAO J A, SANG M X, GENG C Z, et al . A novel curcumin analogue is a potent chemotherapy candidate for human hepatocellular carcinoma[J ] . Oncol Lett, 2016, 12(5): 4252-4262. DOI:10.3892/ol.2016.5126.

HO D W H, LO R C L, CHAN L K, et al . Molecular pathogenesis of hepatocellular carcinoma[J ] . Liver Cancer, 2016, 5(4): 290-302. DOI: 10.1159/000449340.

GARTEN A, GROHMANN T, KLUCKOVA K, et al . Sorafenib-induced apoptosis in hepatocellular carcinoma is reversed by SIRT1[J ] . Int J Mol Sci, 2019, 20(16): 4048. DOI:10.3390/ijms20164048.

XUE F, LIU Y, ZHANG H, et al . Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression[J ] . Onco Targets Ther, 2016, 9: 7253-7261. DOI:10.2147/ott.s116127.

LABEUR T A, HOFSINK Q, TAKKENBERG R B, et al . The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma—a substudy of the SORAMIC trial[J ] . Acta Oncol, 2020, 59(9): 1028-1035. DOI:10.1080/0284186x.2020.1759826.

KULCHESKI F R, CHRISTOFF A P, MARGIS R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker[J]. J Biotechnol, 2016, 238: 42-51. DOI:10.1016/j.jbiotec.2016.09.011.

BRAOUDAKI M, LAMBROU G I, GIANNIKOU K, et al . Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms[J ] . J Hematol Oncol, 2014, 7: 96. DOI:10.1186/s13045-014-0096-y.

LEE R C, FEINBAUM R L, AMBROS V. The C. elegans heterochronic gene Lin-4 encodes small RNAs with antisense complementarity to Lin-14[J]. Cell, 1993, 75(5): 843-854. DOI:10.1016/0092-8674(93)90529-y.

RASKO J E J, WONG J J L. Nuclear microRNAs in normal hemopoiesis and cancer[J]. J Hematol Oncol, 2017, 10(1): 8. DOI:10.1186/s13045-016-0375-x.

EBRAHIMI S O, REⅡSI S. Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis[J]. Arch Gynecol Obstet, 2019, 299(5): 1453-1458. DOI:10.1007/s00404-019-05107-x.

LU M, WANG T, HE M, et al . Tumor suppressor role of miR-3622b-5p in ERBB 2 -positive cancer[J ] . Oncotarget, 2017, 8(14): 23008-23019. DOI:10.18632/oncotarget.14968..

LI M, ZHANG X M, DING X, et al . Long noncoding RNA LINC00460 promotes cell progression by sponging miR-4443 in head and neck squamous cell carcinoma[J ] . Cell Transplant, 2020, 29: 096368972092740. DOI:10.1177/0963689720927405.

LEI W, YAN C, YA J, et al . MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4[J ] . BMC Cancer, 2018, 18(1): 631. DOI:10.1186/s12885-018-4460-0.

HUANG L M, HU C Q, CAO H, et al . MicroRNA-29c increases the chemosensitivity of pancreatic cancer cells by inhibiting USP22 mediated autophagy[J ] . Cell Physiol Biochemi, 2018, 47(2): 747-758. DOI: 10.1159/000490027.

WANG M, CAI W R, MENG R, et al . miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin[J ] . Biochem Biophys Res Commun, 2018, 501(1): 48-54. DOI:10.1016/j.bbrc.2018.04.129.

ZHANG M, ZHANG H, HONG H, et al . MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway[J ] . Am J Cancer Res, 2019, 9(4): 765-778.

LIU K, LIU S Y, ZHANG W, et al . MiR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN[J ] . Oncol Rep, 2015, 34(2): 1003-1010. DOI:10.3892/or.2015.4030.

WANG S, LI M Y, LIU Y, et al . The role of microRNA in cisplatin resistance or sensitivity[J ] . Expert Opin Ther Targets, 2020, 7: 1-13. DOI: 10.1080/14728222.2020.1785431.

ZHANG W, QIAO B, FAN J. Overexpression of miR-4443 promotes the resistance of non-small cell lung cancer cells to epirubicin by targeting INPP4A and regulating the activation of JAK2/STAT3 pathway[J]. Pharmazie, 2018, 73(7): 386-392. DOI:10.1691/ph.2018.8313.

WANG J Y, ZHANG Q, WANG D D, et al . Microenvironment-induced TIMP2 loss by cancer-secreted exosomal miR-4443 promotes liver metastasis of breast cancer[J ] . J Cell Physiol, 2020, 235(7/8): 5722-5735. DOI:10.1002/jcp.29507.

EBRAHIMI S O, REⅡSI S. Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis[J]. Arch Gynecol Obstet, 2019, 299(5): 1453-1458. DOI:10.1007/s00404-019-05107-x.

MEERSON A, YEHUDA H. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells[J]. BMC Cancer, 2016, 16(1): 882. DOI:10.1186/s12885-016-2938-1.

XUN M, MA C F, DU Q L, et al . Differential expression of miRNAs in enterovirus 71-infected cells[J ] . Virol J, 2015, 12: 56. DOI:10.1186/s12985-015-0288-2.

CHEN X, ZHONG S L, LU P, et al . miR-4443 participates in the malignancy of breast cancer[J ] . PLoS ONE, 2016, 11(8): e0160780. DOI:10.1371/journal.pone.0160780.

MEERSON A, YEHUDA H. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells[J]. BMC Cancer, 2016, 16(1):882. DOI:10.1186/s12885-016-2938-1.

LUDDI A, MARROCCO C, GOVERNINI L, et al . Expression of matrix metalloproteinases and their inhibitors in endometrium: high levels in endometriotic lesions[J ] . Int J Mol Sci, 2020, 21(8): 2840. DOI:10.3390/ijms21082840.

MIMORI K, UEO H, SHIRASAKA C, et al . Clinical significance of MT1-MMP mRNA expression in breast cancer[J ] . Oncol Rep, 2001, 8(2): 401-403. DOI:10.3892/or.8.2.401.

CHEN G, GE D, ZHU B, et al . Upregulation of matrix metalloproteinase 9 (MMP9)/tissue inhibitor of metalloproteinase 1 (TIMP1) and MMP2/TIMP2 ratios may be involved in lipopolysacchar ide-induced acute lung injury[J ] . J Int Med Res, 2020, 48(4): 300060520919592. DOI:10.1177/0300060520919592.

PEENEY D, FAN Y, NGUYEN T, et al . Matrisome-associated gene expression patterns correlating with TIMP2 in cancer[J ] . Sci Rep, 2019, 9(1): 20142. DOI:10.1038/s41598-019-56632-3.

AZNAVOORIAN S, MURPHY A N, STETLER-STEVENSON W G, et al . Molecular aspects of tumor cell invasion and metastasis[J ] . Cancer, 1993, 71(4): 1368-1383. DOI:10.1002/1097-0142(19930215)71:41368::aid-cncr2820710432 > 3.0.co; 2-l.

NAGASE H. Cell surface activation of progelatinase A (proMMP-2) and cell migration[J]. Cell Res, 1998, 8(3): 179-186. DOI:10.1038/cr.1998.18.

0

浏览量

0

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

相关文章

激活miR-101-3p/EZH2通路增敏索拉非尼抗肝癌HepG2细胞的效果

缺氧诱导因子-1α纳米抑制剂的构建及在逆转结直肠癌细胞化疗耐药中的应用

胆红素上调PPARα/CPT1A降低Huh7细胞对索拉非尼的敏感性

沉默高迁移率族蛋白B1对胶质母细胞瘤细胞恶性生物学行为的抑制

类鼻疽杆菌通过抑制自噬调控HepG2细胞胞内脂质代谢

相关作者

张越婷

肖翰希

孙梁博

李涛

陈岺曦

闫小晶

何凤田

连继勤

相关机构

陆军军医大学（第三军医大学）第二附属医院消化内科

陆军军医大学(第三军医大学)第一附属医院肿瘤科

陆军军医大学(第三军医大学)第一附属医院病理学研究所

陆军军医大学(第三军医大学)药学与检验医学系临床微生物及免疫学教研室

西南大学生命科学学院，三峡地区生态环境与生物资源国家重点实验室培育基地，现代生物制药研究所

⁰